Litcius/Paper detail

Can treating rheumatoid arthritis with disease-modifying anti-rheumatic drugs at the window of opportunity with tight control strategy lead to long-term remission and medications free remission in real-world clinical practice? A cohort study

Sanaz Ebrahimian, Amin Salami, Aida Malek Mahdavi, Kamal Esalatmanesh, Alireza Khabbazi, Mehrzad Hajialilo

2021Clinical Rheumatology12 citationsDOI

Topics & Concepts

MedicineRheumatoid arthritisRheumatologyWindow of opportunityTherapeutic windowInternal medicineRheumatic diseaseDiseaseLead (geology)Intensive care medicineAntirheumatic AgentsPhysical therapyPharmacologyGeologyComputer scienceReal-time computingGeomorphologyRheumatoid Arthritis Research and TherapiesMusculoskeletal Disorders and RehabilitationGout, Hyperuricemia, Uric Acid
Can treating rheumatoid arthritis with disease-modifying anti-rheumatic drugs at the window of opportunity with tight control strategy lead to long-term remission and medications free remission in real-world clinical practice? A cohort study | Litcius